Barbara J. Mason
Pearson Center for Alcoholism and Addiction Research
The Scripps Research Institute
10550 North Torrey Pines Road
TPC-5
USA
Name/email consistency: high
- The neurobiology, clinical efficacy and safety of acamprosate in the treatment of alcohol dependence. Mason, B.J., Heyser, C.J. Expert. Opin. Drug. Saf (2010)
- Acamprosate: a prototypic neuromodulator in the treatment of alcohol dependence. Mason, B.J., Heyser, C.J. CNS. Neurol. Disord. Drug. Targets (2010)
- Proof-of-concept human laboratory study for protracted abstinence in alcohol dependence: effects of gabapentin. Mason, B.J., Light, J.M., Williams, L.D., Drobes, D.J. Addict. Biol (2009)
- Stress, alcohol craving, and relapse risk: mechanisms and viable treatment targets. Mason, B.J., Shaham, Y., Weiss, F., Le, A.D. Alcohol (2009)
- Effect of positive and negative affective stimuli and beverage cues on measures of craving in non treatment-seeking alcoholics. Mason, B.J., Light, J.M., Escher, T., Drobes, D.J. Psychopharmacology (Berl.) (2008)
- Acamprosate in the treatment of alcohol dependence: clinical and economic considerations. Mason, B.J., Crean, R. Expert. Rev. Neurother (2007)
- Effect of oral acamprosate on abstinence in patients with alcohol dependence in a double-blind, placebo-controlled trial: the role of patient motivation. Mason, B.J., Goodman, A.M., Chabac, S., Lehert, P. J. Psychiatr. Res (2006)
- Acamprosate in the treatment of alcohol dependence. Mason, B.J. Expert. Opin. Pharmacother (2005)
- Rationale for combining acamprosate and naltrexone for treating alcohol dependence. Mason, B.J. J. Stud. Alcohol. Suppl (2005)
- Acamprosate and naltrexone treatment for alcohol dependence: an evidence-based risk-benefits assessment. Mason, B.J. Eur. Neuropsychopharmacol (2003)